Stage II Oropharyngeal Squamous Cell Carcinoma
7 clinical trials · Condition
◉ Watch Stage II Oropharyngeal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (NCT03342911) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-11-13 |
| Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer (NCT02827838) | Wake Forest University Health Sciences | 2017-01-01 |
| Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer (NCT01932697) | Mayo Clinic | 2013-09-04 |
| Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer (NCT01748942) | OHSU Knight Cancer Institute | 2012-12-01 |
| Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery (NCT02007200) | National Cancer Institute (NCI) | 2009-07-01 |
Track Stage II Oropharyngeal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.